8/6/2023 0 Comments Moderna side effect statsLooking at it in yet another way, let’s compare it to the current stats about COVID-19 cases in Australia.īased on the UK percentages, if all Australians contracted COVID-19, 7.7 million of them would get COVID-related blood clots, and 750,000 would likely die from the disease (based on global averages). If we say that that one blood clot is equivalent to 1 metre, then the length of AstraZeneca blood-clot cases per 1,000 km would be the equivalent of 8 metres (about two Volkswagen Beetles, or as tall as one and a half giraffes).įor progestin birth-control pills, that would be 400m (a little under four soccer pitches, or the length of a full-lap Olympic sprint, or eight laps of an Olympic swimming pool), and 2km for pregnancy (the north-south length of Adelaide’s CBD).įor COVID-19 related blood clots, it would be 310km – a little more than the road distance from Sydney to Canberra. Let’s look at that in a different way by equating these stats to distance instead of volume. So, compared to the AstraZeneca vaccine, the chance of blood clots is about 50 times greater for the pill, 2500 times greater for pregnancy, and 38,750 times greater from COVID-19 infection. With an average eight blood-clot cases per million in the UK, the risk of blood clots from the AstraZeneca vaccine is much lower than the risks of blood clot from an oral contraceptive pill ( 400 per million in Australia), pregnancy ( 2000 per million) or severe COVID-19 itself (about 31% of people admitted to the ICU, or 310,000 per million ). For the following examples, assume that the UK stats are broadly reflective of vaccine-related blood clots. Numbers can feel very big if they’re compared to numbers we’re familiar with. Note: The following numbers in this article were updated on April 22 2021. Ultimately, such findings have led to the European Medical Agency recommending that the risk of COVID-19 is greater than the risk of AstraZeneca vaccine side-effects. “Many of these individuals are young and have no pre-existing medical conditions, indicating that even relatively healthy individuals may face long-term impacts from their illness.” “Our study is unique in characterising a group consisting of mostly outpatients: 90% of our cohort experienced only a mild COVID-19 illness, yet one-third continue to have lingering effects. “To our knowledge, this study presents the longest follow-up symptom assessment post-illness, with individuals surveyed out to 9 months after their COVID diagnosis,” she told MedPage Today. “The effects of COVID-19 can linger far beyond acute infection, even in individuals who experienced mild illness,” said author Denise McCulloch of University of Washington. However, this doesn’t reflect an average population, because the first people to receive first-stage vaccinations were healthcare workers, most of whom are women. Likewise, inititally women under the age of 60 appeared to make up the largest portion of cases in Germany, because 29 of the 31 cases were women in the early days. However, we need to bare in mind that vaccination is still only readily available to the eldery, medical staff and some vulnerable groups, and is not reflective of a normal population The median age of linked cases in Australia was 66, which makes it sound like the side-effects are more common in the elderly. All but one of these are recovering and stable. The most common time for onset was 14 days following administration, but had a range of 2-44 days.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |